This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

2022 Information Coming Soon!

Myriam Fabre, Ph.D.
R&D Director at Oncomatryx Biopharma S.L.


Dr Myriam Fabre current position as R&D Director at Oncomatryx Biopharma S.L. in Derio, Spain.

Previously founding partner, Executive Vice-President and R&D Manager at Advancell, a biopharmaceutical company specialized in Oncology drug development in Barcelona, Spain.

With more than 20-year experience in cancer research and biopharmaceutical industry.

Awarded with a Postdoctoral fellowship from the Rockefeller University, NYC.

She holds a PhD in Molecular Biology and a degree in Biochemistry from the University Paul Sabatier, Toulouse, France, and a Master in Business from EADA.

Agenda Sessions

  • FAP-targeting OMTX705 ADC, A Novel Stroma-directed Treatment Alternative for Chemotherapy- and Pembrolizumab-resistant Solid Tumors

    On Demand
  • Payloaded Antibodies and Immune-oncology – Crossroads


Speakers at this event